CLINICAL_TRIALS
trial_result
· 2016-05-17
Clinical Trial Update: Safety Study of SLC-0111 in Subjects With Advanced Solid Tumours [Phase 1]
Summary
The document reports the completion of a Phase 1 safety study of the investigational drug SLC-0111 in subjects with advanced solid tumors.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Welichem Biotech Inc. | Conditions: Solid Tumours | Phase 1 | Status: COMPLETED